Dermapharm Holding SE (LTS:0A5J) Change In Receivables : €0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Dermapharm Holding SE Change In Receivables?

Dermapharm Holding SE's change in receivables for the quarter that ended in Dec. 2024 was €0 Mil. It means Dermapharm Holding SE's Accounts Receivable stayed the same from Sep. 2024 to Dec. 2024 .

Dermapharm Holding SE's change in receivables for the fiscal year that ended in Dec. 2024 was €0 Mil. It means Dermapharm Holding SE's Accounts Receivable stayed the same from Dec. 2023 to Dec. 2024 .

Dermapharm Holding SE's Accounts Receivable for the quarter that ended in Dec. 2024 was €101 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Dermapharm Holding SE's Days Sales Outstanding for the three months ended in Dec. 2024 was 31.68.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Dermapharm Holding SE's liquidation value for the three months ended in Dec. 2024 was €-1,104 Mil.

Dermapharm Holding SE Change In Receivables Historical Data

The historical data trend for Dermapharm Holding SE's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dermapharm Holding SE Change In Receivables Chart

Dermapharm Holding SE Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

Dermapharm Holding SE Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Dermapharm Holding SE Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

Dermapharm Holding SE (LTS:0A5J) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Dermapharm Holding SE's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	100.9	/	290.67	*	91
=	31.68

2. In Ben Graham's calculation of liquidation value, Dermapharm Holding SE's accounts receivable are only considered to be worth 75% of book value:

Dermapharm Holding SE's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	121.706	-	1471.724	+	0.75 * 100.9	+	0.5 * 339.856
=	-1,104

Dermapharm Holding SE Change In Receivables Related Terms

Thank you for viewing the detailed overview of Dermapharm Holding SE's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Dermapharm Holding SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dermapharm Holding SE (LTS:0A5J) » Definitions » Change In Receivables

Traded in Other Exchanges

DMPHF:USA DMPd:UK DMP:Germany

Address

Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031

Website

https://www.dermapharm.com

Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.

Dermapharm Holding SE Headlines

No Headlines